Pegylated interferon–induced immune‐mediated hepatitis post–liver transplantation
A 55‐year‐old Caucasian male developed a well characterized autoimmune hepatitis after completing treatment with pegylated interferon and ribavirin for recurrent hepatitis C. We hypothesize that pegylated interferon triggered a severe form of immune‐mediated hepatitis.
Gespeichert in:
| Veröffentlicht in: | Liver transplantation 2006-05, Vol.12 (5), p.827-830 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 830 |
|---|---|
| container_issue | 5 |
| container_start_page | 827 |
| container_title | Liver transplantation |
| container_volume | 12 |
| creator | Kontorinis, Nickolas Agarwal, Kaushik Elhajj, Nassim Fiel, M. Isabel Schiano, Thomas D. |
| description | A 55‐year‐old Caucasian male developed a well characterized autoimmune hepatitis after completing treatment with pegylated interferon and ribavirin for recurrent hepatitis C. We hypothesize that pegylated interferon triggered a severe form of immune‐mediated hepatitis. |
| doi_str_mv | 10.1002/lt.20706 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_902330682</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>902330682</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2796-2b9827c1adfab2f14621db8d3f195fca3ac26cf9eb956e52fe458abee7b442eb3</originalsourceid><addsrcrecordid>eNpFkM1KAzEUhYMotlbBJ5DuXE1NMjOZyVKKf1DQRcVlSGZuNJL5MclYuusjCL5hn8Tpj7o6l3s-LvcchM4JnhCM6ZUNE4ozzA7QkKQ0i1iSxYd_M0sH6MT7d4wJSTk-RgPCGM0Z50P08gSvSysDlGNTB3AaXFOvV9-mLrtis6yqrob16quC0myxN2hlMMH4cdv40KPWfIIbBydr31pZh95t6lN0pKX1cLbXEXq-vZlP76PZ493D9HoWtTTjLKKK5zQriCy1VFSThFFSqryMNeGpLmQsC8oKzUHxlEFKNSRpLhVAppKEgopH6HJ3t3XNRwc-iMr4Amz_CDSdFxzTOMYspz15sSc71YcRrTOVdEvx20UPRDtgYSws_30sNh0LG8S2YzGbbzX-AbPkc4w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>902330682</pqid></control><display><type>article</type><title>Pegylated interferon–induced immune‐mediated hepatitis post–liver transplantation</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Kontorinis, Nickolas ; Agarwal, Kaushik ; Elhajj, Nassim ; Fiel, M. Isabel ; Schiano, Thomas D.</creator><creatorcontrib>Kontorinis, Nickolas ; Agarwal, Kaushik ; Elhajj, Nassim ; Fiel, M. Isabel ; Schiano, Thomas D.</creatorcontrib><description>A 55‐year‐old Caucasian male developed a well characterized autoimmune hepatitis after completing treatment with pegylated interferon and ribavirin for recurrent hepatitis C. We hypothesize that pegylated interferon triggered a severe form of immune‐mediated hepatitis.</description><identifier>ISSN: 1527-6465</identifier><identifier>EISSN: 1527-6473</identifier><identifier>DOI: 10.1002/lt.20706</identifier><identifier>PMID: 16628699</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>alpha -Interferon ; Antiviral Agents - adverse effects ; Hepatitis C ; Hepatitis C - complications ; Hepatitis C - drug therapy ; Hepatitis, Autoimmune - etiology ; Humans ; Interferon ; Interferon-alpha - adverse effects ; Liver Cirrhosis - surgery ; Liver Transplantation - adverse effects ; Male ; Middle Aged ; Polyethylene Glycols - adverse effects ; Recombinant Proteins ; Ribavirin</subject><ispartof>Liver transplantation, 2006-05, Vol.12 (5), p.827-830</ispartof><rights>Copyright © 2006 American Association for the Study of Liver Diseases</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Flt.20706$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Flt.20706$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16628699$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kontorinis, Nickolas</creatorcontrib><creatorcontrib>Agarwal, Kaushik</creatorcontrib><creatorcontrib>Elhajj, Nassim</creatorcontrib><creatorcontrib>Fiel, M. Isabel</creatorcontrib><creatorcontrib>Schiano, Thomas D.</creatorcontrib><title>Pegylated interferon–induced immune‐mediated hepatitis post–liver transplantation</title><title>Liver transplantation</title><addtitle>Liver Transpl</addtitle><description>A 55‐year‐old Caucasian male developed a well characterized autoimmune hepatitis after completing treatment with pegylated interferon and ribavirin for recurrent hepatitis C. We hypothesize that pegylated interferon triggered a severe form of immune‐mediated hepatitis.</description><subject>alpha -Interferon</subject><subject>Antiviral Agents - adverse effects</subject><subject>Hepatitis C</subject><subject>Hepatitis C - complications</subject><subject>Hepatitis C - drug therapy</subject><subject>Hepatitis, Autoimmune - etiology</subject><subject>Humans</subject><subject>Interferon</subject><subject>Interferon-alpha - adverse effects</subject><subject>Liver Cirrhosis - surgery</subject><subject>Liver Transplantation - adverse effects</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Polyethylene Glycols - adverse effects</subject><subject>Recombinant Proteins</subject><subject>Ribavirin</subject><issn>1527-6465</issn><issn>1527-6473</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkM1KAzEUhYMotlbBJ5DuXE1NMjOZyVKKf1DQRcVlSGZuNJL5MclYuusjCL5hn8Tpj7o6l3s-LvcchM4JnhCM6ZUNE4ozzA7QkKQ0i1iSxYd_M0sH6MT7d4wJSTk-RgPCGM0Z50P08gSvSysDlGNTB3AaXFOvV9-mLrtis6yqrob16quC0myxN2hlMMH4cdv40KPWfIIbBydr31pZh95t6lN0pKX1cLbXEXq-vZlP76PZ493D9HoWtTTjLKKK5zQriCy1VFSThFFSqryMNeGpLmQsC8oKzUHxlEFKNSRpLhVAppKEgopH6HJ3t3XNRwc-iMr4Amz_CDSdFxzTOMYspz15sSc71YcRrTOVdEvx20UPRDtgYSws_30sNh0LG8S2YzGbbzX-AbPkc4w</recordid><startdate>200605</startdate><enddate>200605</enddate><creator>Kontorinis, Nickolas</creator><creator>Agarwal, Kaushik</creator><creator>Elhajj, Nassim</creator><creator>Fiel, M. Isabel</creator><creator>Schiano, Thomas D.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>200605</creationdate><title>Pegylated interferon–induced immune‐mediated hepatitis post–liver transplantation</title><author>Kontorinis, Nickolas ; Agarwal, Kaushik ; Elhajj, Nassim ; Fiel, M. Isabel ; Schiano, Thomas D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2796-2b9827c1adfab2f14621db8d3f195fca3ac26cf9eb956e52fe458abee7b442eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>alpha -Interferon</topic><topic>Antiviral Agents - adverse effects</topic><topic>Hepatitis C</topic><topic>Hepatitis C - complications</topic><topic>Hepatitis C - drug therapy</topic><topic>Hepatitis, Autoimmune - etiology</topic><topic>Humans</topic><topic>Interferon</topic><topic>Interferon-alpha - adverse effects</topic><topic>Liver Cirrhosis - surgery</topic><topic>Liver Transplantation - adverse effects</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Polyethylene Glycols - adverse effects</topic><topic>Recombinant Proteins</topic><topic>Ribavirin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kontorinis, Nickolas</creatorcontrib><creatorcontrib>Agarwal, Kaushik</creatorcontrib><creatorcontrib>Elhajj, Nassim</creatorcontrib><creatorcontrib>Fiel, M. Isabel</creatorcontrib><creatorcontrib>Schiano, Thomas D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Liver transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kontorinis, Nickolas</au><au>Agarwal, Kaushik</au><au>Elhajj, Nassim</au><au>Fiel, M. Isabel</au><au>Schiano, Thomas D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pegylated interferon–induced immune‐mediated hepatitis post–liver transplantation</atitle><jtitle>Liver transplantation</jtitle><addtitle>Liver Transpl</addtitle><date>2006-05</date><risdate>2006</risdate><volume>12</volume><issue>5</issue><spage>827</spage><epage>830</epage><pages>827-830</pages><issn>1527-6465</issn><eissn>1527-6473</eissn><abstract>A 55‐year‐old Caucasian male developed a well characterized autoimmune hepatitis after completing treatment with pegylated interferon and ribavirin for recurrent hepatitis C. We hypothesize that pegylated interferon triggered a severe form of immune‐mediated hepatitis.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>16628699</pmid><doi>10.1002/lt.20706</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1527-6465 |
| ispartof | Liver transplantation, 2006-05, Vol.12 (5), p.827-830 |
| issn | 1527-6465 1527-6473 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_902330682 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection |
| subjects | alpha -Interferon Antiviral Agents - adverse effects Hepatitis C Hepatitis C - complications Hepatitis C - drug therapy Hepatitis, Autoimmune - etiology Humans Interferon Interferon-alpha - adverse effects Liver Cirrhosis - surgery Liver Transplantation - adverse effects Male Middle Aged Polyethylene Glycols - adverse effects Recombinant Proteins Ribavirin |
| title | Pegylated interferon–induced immune‐mediated hepatitis post–liver transplantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T00%3A15%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pegylated%20interferon%E2%80%93induced%20immune%E2%80%90mediated%20hepatitis%20post%E2%80%93liver%20transplantation&rft.jtitle=Liver%20transplantation&rft.au=Kontorinis,%20Nickolas&rft.date=2006-05&rft.volume=12&rft.issue=5&rft.spage=827&rft.epage=830&rft.pages=827-830&rft.issn=1527-6465&rft.eissn=1527-6473&rft_id=info:doi/10.1002/lt.20706&rft_dat=%3Cproquest_pubme%3E902330682%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=902330682&rft_id=info:pmid/16628699&rfr_iscdi=true |